These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15692103)

  • 1. Antiangiogenic activity of a domain deletion mutant of tissue plasminogen activator containing kringle 2.
    Carroll VA; Nikitenko LL; Bicknell R; Harris AL
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):736-41. PubMed ID: 15692103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator.
    Kim HK; Lee SY; Oh HK; Kang BH; Ku HJ; Lee Y; Shin JY; Hong YK; Joe YA
    Biochem Biophys Res Commun; 2003 May; 304(4):740-6. PubMed ID: 12727218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
    Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
    Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
    Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
    Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
    Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
    J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.
    Su L; Xu X; Zhao H; Gu Q; Zou H
    Biochem Biophys Res Commun; 2010 Jun; 396(4):1012-7. PubMed ID: 20471363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DGDA, a local sequence of the kringle 2 domain, is a functional motif of the tissue-type plasminogen activator's antiangiogenic kringle domain.
    Kim HK; Joe YA
    Biochem Biophys Res Commun; 2010 Jan; 391(1):166-9. PubMed ID: 19903452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity.
    Lee H; Kim HK; Lee JH; You WK; Chung SI; Chang SI; Park MH; Hong YK; Joe YA
    Arch Biochem Biophys; 2000 Mar; 375(2):359-63. PubMed ID: 10700393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
    Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
    Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kringle domain of tissue-type plasminogen activator inhibits extracellular matrix-induced adhesion and migration of endothelial cells.
    Lee BH; Kim HK; Joe YA
    Biosci Biotechnol Biochem; 2008 Sep; 72(9):2303-8. PubMed ID: 18776698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
    Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
    J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain.
    Kim KS; Hong YK; Lee Y; Shin JY; Chang SI; Chung SI; Joe Y
    Exp Mol Med; 2003 Dec; 35(6):578-85. PubMed ID: 14749538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
    Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
    FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
    Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J
    J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells.
    Lu H; Dhanabal M; Volk R; Waterman MJ; Ramchandran R; Knebelmann B; Segal M; Sukhatme VP
    Biochem Biophys Res Commun; 1999 May; 258(3):668-73. PubMed ID: 10329443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system.
    Liu L; Boffa MB; Koschinsky ML
    PLoS One; 2013; 8(1):e52287. PubMed ID: 23326327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the non-glycosylated kringle domain of tissue type plasminogen activator in Pichia and its anti-endothelial cell activity.
    Lee SB; Oh HK; Kim HK; Joe YA
    Protein Expr Purif; 2006 Nov; 50(1):1-8. PubMed ID: 16854593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and expression of a gene from kringle-2 domain of tissue plasminogen activator in E. coli.
    Hua ZC; Fu HL; Chen YH; Yu RR; Wang J; Zhu DX
    Sci China B; 1994 Jun; 37(6):667-76. PubMed ID: 7917003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
    Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
    Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-type plasminogen activator domain-deletion mutant BM 06.022: modular stability, inhibitor binding, and activation cleavage.
    Hu CK; Kohnert U; Wilhelm O; Fischer S; Llinás M
    Biochemistry; 1994 Oct; 33(39):11760-6. PubMed ID: 7918392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.